Tweet
Cambridge Healthtech Institute is proud to announce the production of two sequencing conferences in one convenient location. Join us this summer (August 13-15) in Providence, Rhode Island for in-depth presentations, interactive discussion groups, short courses, and networking opportunities. Registration grants you access to both meetings, allowing you to create an agenda that best fits your research needs. Just choose from the concurrent programs:
CHI's Seventh Annual NGx: Applying Next-Generation Sequencing conference investigates the expanding applications of Next-Generation Sequencing (NGS).NGS has expanded our fundamental understanding of genomics, mutation, gene function and regulation, by delivering fast, precise, and large volumes of data. As the cost of sequencing declines, use in academic, biotech, medical, pharmaceutical, and ag-bio labs expands, paving the way for the creation of innovative new areas for ioresearch. Still, the question remains of how best to balance cost, quantity and quality when choosing a sequencing platform or service. Learn more at http://www.healthtech.com/sda
CHI's Fifth Annual Next-Generation Sequencing Data Analysis conference delivers unique perspectives from a variety of researchers, engineers, biostatisticians, and software developers involved in NGS data analysis. Explore the layers of analysis necessary to convert raw sequence data into understanding of functional biology. Topics include accounting for error sources in the original raw data from multiple platforms and diverse applications, the advancement of computational methods for assembly, alignment, and variation detection, to addressing a broad range of genetic analysis applications including comparative genomics, high-throughput polymorphism detection, analysis of coding and non-coding RNAs, and identifying mutant genes in disease pathways. Learn more at http://www.healthtech.com/sqe
CHI's Seventh Annual NGx: Applying Next-Generation Sequencing conference investigates the expanding applications of Next-Generation Sequencing (NGS).NGS has expanded our fundamental understanding of genomics, mutation, gene function and regulation, by delivering fast, precise, and large volumes of data. As the cost of sequencing declines, use in academic, biotech, medical, pharmaceutical, and ag-bio labs expands, paving the way for the creation of innovative new areas for ioresearch. Still, the question remains of how best to balance cost, quantity and quality when choosing a sequencing platform or service. Learn more at http://www.healthtech.com/sda
CHI's Fifth Annual Next-Generation Sequencing Data Analysis conference delivers unique perspectives from a variety of researchers, engineers, biostatisticians, and software developers involved in NGS data analysis. Explore the layers of analysis necessary to convert raw sequence data into understanding of functional biology. Topics include accounting for error sources in the original raw data from multiple platforms and diverse applications, the advancement of computational methods for assembly, alignment, and variation detection, to addressing a broad range of genetic analysis applications including comparative genomics, high-throughput polymorphism detection, analysis of coding and non-coding RNAs, and identifying mutant genes in disease pathways. Learn more at http://www.healthtech.com/sqe
Comment